FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileEpigenomics AG
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EPGNF
Epigenomics AG Stock AnalysisComprehensive stock analysis for Epigenomics AG (EPGNF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEPGNF
EPGNF
Epigenomics AG
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
EPGNF
  1. Home
  2. Stocks
  3. Epigenomics AG

Epigenomics AG

🇺🇸EPGNF•OTC

Epigenomics AG

🇺🇸EPGNF•OTC
Market cap
$982.18K

Your view on EPGNF

Mkt Cap
$982.18K
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Epigenomics AG

Industry
Medical - Specialties
Sector
Healthcare
CEO
Noel Thomas Doheny
Headquarters
Geneststrasse 5, Heidelberg, DE
Industry
Medical - Specialties
Sector
Healthcare
CEO
Noel Thomas Doheny
Headquarters
Geneststrasse 5, Heidelberg, DE
Description

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China.

The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA.

Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Epigenomics AG. Starting points for Epigenomics AG: EPS -$0.36, beta 0.77 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Epigenomics AG. Epigenomics AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Epigenomics AG. Trailing twelve-month EPS for Epigenomics AG stands at -$0.36. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · EUR

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent YearFY Dec 2016Next YearFY Dec 2017
Avg. estimate−EUR 76.59−EUR 79.79
Low estimate−EUR 76.59−EUR 79.79
High estimate−EUR 76.59−EUR 79.79
No. of analysts11
Year-ago EPS——
Growth——

Revenue Estimate

RevenueCurrent YearFY Dec 2016Next YearFY Dec 2017
Avg. estimateEUR 4.37MEUR 1.25M
Low estimateEUR 4.37MEUR 1.25M
High estimateEUR 4.37MEUR 1.25M
No. of analysts11
Year-ago revenue——
Growth——

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Epigenomics AG. Epigenomics AG has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold EPGNF20 companies
Compare EPGNF with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
BMMJBody and Mind Inc.HealthcareDrug Manufacturers - Specialty & Generic$14,769
CHMEChina Medicine CorporationHealthcareMedical - Pharmaceuticals$829,922
CHYPFHealth Logic Interactive Inc.HealthcareMedical - Devices$165,839
NGMCNext Generation Management Corp.IndustrialsSpecialty Business Services$717
NSTMNovelStem International Corp.HealthcareMedical - Diagnostics & Research$653,997
PCYNProcyon CorporationHealthcareDrug Manufacturers - Specialty & Generic$1.5M
PPJEPPJ Healthcare Enterprises, Inc.HealthcareMedical - Healthcare Information Services$890,484
RSHNRushNet, Inc.HealthcareMedical - Diagnostics & Research$857,642
More Medical - Specialties companies
TickerTypeCompanySectorExchangeMkt cap
DRIODarioHealth Corp.HealthcareNASDAQ$16.5M
FEEDENvue Medical, Inc.HealthcareNASDAQ$951,429
GENXGenex Pharmaceutical, Inc.HealthcareOTC$1,788
HLTHQCue Health Inc.HealthcareOTC$159
IDTAIDenta Corp.HealthcareOTC$1.1M
IMR.AXImricor Medical Systems, Inc.HealthcareASX—
ITOCiTonic Holdings Ltd.HealthcareNASDAQ$10.7M
KKURChromoCure, Inc.HealthcareOTC$8,200
LABStandard BioTools Inc.HealthcareNASDAQ$225.0M
LANZLancer Orthodontics, Inc.HealthcareOTC$74,488
LDX.AXLumos Diagnostics Holdings LimitedHealthcareASX—
LDXHFLumos Diagnostics Holdings LimitedHealthcareOTC$158.6M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Epigenomics AG. Coverage tracks Epigenomics AG within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Epigenomics AG.

EPGNF AnalysisWeak
Past
2
Growth
1
Health
2
Profit
1
Value
1

News

Latest Market News